Bioneex has an additional data layer that includes over 2,000 drug development companies submitting asset information directly to the platform, including non-confidential company decks.
Published
Signal category
Products & Services
Quote
“More than 2,000 drug development companies have submitted asset information directly to Bioneex, including non-confidential company decks.”
— Bioneex team
Company
Bioneex
Find Investors and Partners | Search and Evaluate Assets
- Industry
- Technology, Information and Internet
- Location
- Syracuse, US
- Company size
- 20 employees
On One Side: Bioneex is an AI-powered platform that connects drug development companies with strategic biopharma partners and venture capital investors to facilitate licensing, co-development partnerships, and investments. On the Other Side: Bioneex is an AI-powered platform for the search, evaluation, and due diligence of therapeutic assets that connects directly with drug development companies. Exclusively on Bioneex, you can access assets that have been de-risked through a predictive AI simulating human biology – Derisq™ – conducted by our partner company, GATC Health. Among our clients are some of the top biopharmaceutical companies and venture capital firms, such as Johnson & Johnson, Bayer, AbbVie, GSK, BioNTech, Sofinnova Partners, Curie.Bio, Andera Life Sciences, Apple Tree Partners, TVM Capital Life Science, and ALSA Ventures, which are actively looking for therapeutic assets to in-license, co-develop, and invest in. Bioneex's vision is helping preclinical and clinical-stage drug development companies gain for their medicines in development vital exposure to the right partners and investors at the right time, which will increase the likelihood of moving these innovative drug candidates and technologies into the next stage of development and, ultimately to the patients as novel medicines.
Founded 2020